Brief: EQL Pharma Q3 EBIT SEK 15.5 Million

EQL Pharma AB

14/02/2023 07:13

Feb 14 (Reuters) - EQL Pharma Q3 revenue SEK 80.2 million.
* Q3 adjusted revenue SEK 56.1 million
* Q3 EBIT margin 19%
* Q3 adjusted free cash flow SEK -2.1 million
* Q3 EPS SEK 0.41